Evidence map›Paper›PMID 28546549›Full record

ArticleImmunology and cell biology2017

Restimulation-induced T-cell death through NTB-A/SAP signaling pathway is impaired in tuberculosis patients with depressed immune responses.

Rodrigo E Hernández Del Pino, Joaquín M Pellegrini, Ana I Rovetta, Delfina Peña, Guadalupe I Álvarez, Agustín Rolandelli, Rosa M Musella, Domingo J Palmero, Alejandro Malbran, Virginia Pasquinelli and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunology and cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Rodrigo E Hernández Del PinoDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, UBA, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires, Argentina.
Joaquín M PellegriniDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, UBA, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires, Argentina.
Ana I RovettaDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, UBA, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires, Argentina.
Delfina PeñaDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, UBA, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires, Argentina.
Guadalupe I ÁlvarezDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, UBA, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires, Argentina.
Agustín RolandelliDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, UBA, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires, Argentina.
Rosa M MusellaDivisión Tisioneumonología Hospital F.J. Muñiz, Uspallata 2272, Buenos Aires, Argentina.
Domingo J PalmeroDivisión Tisioneumonología Hospital F.J. Muñiz, Uspallata 2272, Buenos Aires, Argentina.
Alejandro MalbranUnidad de Alergia, Asma e Inmunología Clínica, Hospital Británico de Buenos Aires. Av. Roque Saenz Peña 1160, 1°piso, Buenos Aires, Argentina.
Virginia PasquinelliDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, UBA, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires, Argentina.
Verónica E GarcíaDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, UBA, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires, Argentina.
University of Buenos Aires · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARHospital Muñiz · ARFundación Ciencias Exactas y Naturales · ARHospital Británico de Buenos Aires · ARNational University of Northwestern Buenos Aires · AR

Funding

Signaling pathways that regulate IFN-g production in human tuberculosis.R01AI079007 · NIAID · FACULTAD DE CIENCIAS EXACTAS Y NATURALES DE LA UNIVERSIDAD DE BUENOS AIRES · PI GARCIA, VERONICA EDITH · 2009 to 2012
$287k
NIAID NIH HHS R01 AI079007
6 · The paper itself

Abstract

Production of IFN-γ contributes to host defense against Mycobacterium tuberculosis (Mtb) infection. We previously demonstrated that Signaling lymphocytic activation molecule-associated protein (SAP) expression on cells from tuberculosis (TB) patients was inversely correlated with IFN-γ production. Here we first investigated the role of NK, T- and B-cell antigen (NTB-A)/SAP pathway in the regulation of Th1 response against Mtb. Upon antigen stimulation, NTB-A phosphorylation rapidly increases and afterwards modulates IFN-γ and IL-17 secretion. To sustain a healthy immune system, controlled expansion and contraction of lymphocytes, both during and after an adaptive immune response, is essential. Besides, restimulation-induced cell death (RICD) results in an essential homeostatic mechanism for precluding excess T-cell accumulation and associated immunopathology during the course of certain infections. Accordingly, we found that the NTB-A/SAP pathway was required for RICD during active tuberculosis. In low responder (LR) TB patients, impaired RICD was associated with diminished FASL levels, IL-2 production and CD25

Indexed as

AdultCell DeathCell DifferentiationCells, CulturedFemaleHomeostasisHumansImmunityImmunosuppression TherapyInterferon-gammaInterleukin-17Lymphocyte ActivationMaleMycobacterium tuberculosisNeoplasm ProteinsProtein-Tyrosine KinasesFRK protein, humanInterferon-gammaInterleukin-17Neoplasm ProteinsProtein-Tyrosine KinasesSignaling Lymphocytic Activation Molecule FamilySLAMF6 protein, human

Identifiers

PMID28546549
PMCPMC5595630
OpenAlexW2620049826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.